Knight Therapeutics Net Income Over Time
| GUD Stock | CAD 5.89 0.03 0.51% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Knight Therapeutics Performance and Knight Therapeutics Correlation. Knight |
Cross Equities Net Income Analysis
Compare Knight Therapeutics and related stocks such as Cipher Pharmaceuticals, Vitalhub Corp, and Aurora Cannabis Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CPH | (9.9 M) | (2.3 M) | 2.6 M | 23.4 M | (4.8 M) | 1.8 M | (39.1 M) | 4.4 M | 543 K | 3.2 M | 4.5 M | 7.8 M | 26.6 M | 20.4 M | 11.5 M | 13.3 M | 13.9 M |
| VHI | (2.1 M) | (2.1 M) | (2.1 M) | (2.1 M) | (2.1 M) | (152 K) | (1.4 M) | (2.4 M) | (862.4 K) | (625.5 K) | (2.2 M) | (1.9 M) | 1.2 M | 4.5 M | 3 M | 3.4 M | 3.6 M |
| ACB | 1.3 K | (315.8 K) | (393.5 K) | (399.7 K) | (9.5 M) | (5.7 M) | (13 M) | 71.9 M | (293.5 M) | (3.3 B) | (693.6 M) | (1.7 B) | (265.3 M) | (69.3 M) | 1.6 M | 1.4 M | 1.5 M |
| WEED | (26.9 K) | (21.4 K) | (64.6 K) | (932.9 K) | (8.9 M) | (3.5 M) | (16.6 M) | (54.1 M) | (670.1 M) | (1.4 B) | (1.7 B) | (310 M) | (3.3 B) | (657.3 M) | (598.1 M) | (8.9 M) | (9.4 M) |
| KSI | (39.9 M) | (39.9 M) | (39.9 M) | (39.9 M) | (1.5 M) | (2.2 M) | (7 M) | (660.7 K) | (4.6 M) | (6.3 M) | (5.9 M) | (9.9 M) | (9.1 M) | (14.1 M) | (7.7 M) | (8.9 M) | (9.3 M) |
| TSND | (867.2 K) | (867.2 K) | (867.2 K) | (867.2 K) | (867.2 K) | (867.2 K) | (867.2 K) | (6.8 M) | (22 M) | (215.8 M) | (155.1 M) | 5 M | (577.1 M) | (91.1 M) | (80.2 M) | (72.2 M) | (75.8 M) |
| OGI | (140.2 K) | (140.2 K) | (375.2 K) | (239 K) | (1.3 M) | 846.7 K | (10.9 M) | 20.5 M | (9.5 M) | (136.2 M) | (130.7 M) | (14.3 M) | (229.5 M) | (45.4 M) | (24.8 M) | (22.3 M) | (23.4 M) |
Knight Therapeutics and related stocks such as Cipher Pharmaceuticals, Vitalhub Corp, and Aurora Cannabis Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Knight Therapeutics financial statement analysis. It represents the amount of money remaining after all of Knight Therapeutics operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Knight Therapeutics | GUD |
Specialization | Healthcare, Drug Manufacturers - Specialty & Generic |
| Business Address | 3400 de Maisonneuve |
| Exchange | Toronto Exchange |
CAD 5.89
Other Information on Investing in Knight Stock
Knight Therapeutics financial ratios help investors to determine whether Knight Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Knight with respect to the benefits of owning Knight Therapeutics security.